Prothena Corp. Plc (PRTA)
8.92
-0.10
(-1.11%)
USD |
NASDAQ |
Sep 11, 16:00
8.92
0.00 (0.00%)
After-Hours: 16:54
Prothena Gross Profit (TTM) : 50.81M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 50.81M |
| March 31, 2026 | 54.25M |
| December 31, 2025 | 6.007M |
| September 30, 2025 | 8.138M |
| June 30, 2025 | 6.744M |
| March 31, 2025 | 134.33M |
| December 31, 2024 | 131.57M |
| September 30, 2024 | 116.39M |
| June 30, 2024 | 198.87M |
| March 31, 2024 | 69.96M |
| December 31, 2023 | 71.21M |
| September 30, 2023 | 133.38M |
| June 30, 2023 | 50.82M |
| March 31, 2023 | 48.61M |
| December 31, 2022 | 48.20M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -0.065M |
| June 30, 2014 | -0.038M |
| March 31, 2014 | -0.018M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Alkermes Plc | 1.370B |
| Amarin Corp. Plc | 75.12M |
| Agenus, Inc. | 127.32M |
| Amgen, Inc. | 27.78B |
| Anika Therapeutics, Inc. | 75.00M |